Mersana Therapeutics
MRSN
MRSN
53 hedge funds and large institutions have $342M invested in Mersana Therapeutics in 2018 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
-3
Holders Change %
-5.36%
% of All Funds
1.22%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
11
Increased
20
Reduced
12
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
GTC
1
Ghost Tree Capital
New York
|
$10.7M |
| 2 |
ACH
2
ArrowMark Colorado Holdings
Denver,
Colorado
|
$22.3M |
| 3 |
3
BlackRock
New York
|
$18M |
| 4 |
4
Millennium Management
New York
|
$2.2M |
| 5 |
5
Balyasny Asset Management
Chicago,
Illinois
|
$1.48M |
